Xencor, Inc. (XNCR)
NASDAQ: XNCR · Real-Time Price · USD
12.81
+0.28 (2.23%)
At close: Apr 2, 2026, 4:00 PM EDT
13.90
+1.09 (8.51%)
After-hours: Apr 2, 2026, 7:57 PM EDT
Xencor Market Cap
Xencor has a market cap or net worth of $939.47 million as of April 2, 2026. Its market cap has increased by 1.47% in one year.
Market Cap
939.47M
Enterprise Value
403.88M
1-Year Change
1.47%
Ranking
Category
Stock Price
$12.81
Market Cap Chart
Since December 3, 2013, Xencor's market cap has increased from $245.40M to $939.47M, an increase of 282.83%. That is a compound annual growth rate of 11.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 939.50M | -14.07% |
| Dec 31, 2025 | 1.09B | -32.02% |
| Dec 31, 2024 | 1.61B | 24.44% |
| Dec 29, 2023 | 1.29B | -17.18% |
| Dec 30, 2022 | 1.56B | -33.50% |
| Dec 31, 2021 | 2.35B | -6.40% |
| Dec 31, 2020 | 2.51B | 28.51% |
| Dec 31, 2019 | 1.95B | -4.07% |
| Dec 31, 2018 | 2.03B | 97.53% |
| Dec 29, 2017 | 1.03B | -4.93% |
| Dec 30, 2016 | 1.08B | 82.97% |
| Dec 31, 2015 | 591.80M | 17.51% |
| Dec 31, 2014 | 503.60M | 87.28% |
| Dec 31, 2013 | 268.90M | 9.58% |
| Dec 3, 2013 | 245.40M | - |
View and export this data all the way back to 2013. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CytomX Therapeutics | 953.34M |
| Aktis Oncology | 950.19M |
| Inhibrx Biosciences | 927.98M |
| UroGen Pharma | 926.91M |
| MapLight Therapeutics | 920.10M |
| Janux Therapeutics | 898.48M |
| GH Research | 896.95M |
| Fortrea Holdings | 890.12M |